全文获取类型
收费全文 | 3065篇 |
免费 | 195篇 |
国内免费 | 58篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 102篇 |
妇产科学 | 25篇 |
基础医学 | 421篇 |
口腔科学 | 58篇 |
临床医学 | 403篇 |
内科学 | 611篇 |
皮肤病学 | 71篇 |
神经病学 | 194篇 |
特种医学 | 393篇 |
外国民族医学 | 1篇 |
外科学 | 395篇 |
综合类 | 37篇 |
一般理论 | 3篇 |
预防医学 | 162篇 |
眼科学 | 56篇 |
药学 | 165篇 |
中国医学 | 3篇 |
肿瘤学 | 206篇 |
出版年
2021年 | 27篇 |
2020年 | 24篇 |
2019年 | 28篇 |
2018年 | 43篇 |
2017年 | 37篇 |
2016年 | 32篇 |
2015年 | 40篇 |
2014年 | 53篇 |
2013年 | 101篇 |
2012年 | 98篇 |
2011年 | 103篇 |
2010年 | 90篇 |
2009年 | 104篇 |
2008年 | 83篇 |
2007年 | 112篇 |
2006年 | 86篇 |
2005年 | 102篇 |
2004年 | 61篇 |
2003年 | 77篇 |
2002年 | 74篇 |
2001年 | 88篇 |
2000年 | 75篇 |
1999年 | 78篇 |
1998年 | 93篇 |
1997年 | 104篇 |
1996年 | 122篇 |
1995年 | 81篇 |
1994年 | 76篇 |
1993年 | 71篇 |
1992年 | 68篇 |
1991年 | 66篇 |
1990年 | 82篇 |
1989年 | 87篇 |
1988年 | 89篇 |
1987年 | 74篇 |
1986年 | 86篇 |
1985年 | 92篇 |
1984年 | 48篇 |
1983年 | 62篇 |
1982年 | 38篇 |
1981年 | 30篇 |
1980年 | 35篇 |
1979年 | 44篇 |
1978年 | 26篇 |
1977年 | 22篇 |
1976年 | 24篇 |
1975年 | 33篇 |
1974年 | 28篇 |
1973年 | 19篇 |
1971年 | 14篇 |
排序方式: 共有3318条查询结果,搜索用时 283 毫秒
1.
2.
3.
Ophira Salomon Joseph Moisseiev Tamara Vilganski Rima Dardik Shimon Kurtz Eva Shpringer David M Steinberg Nurit Rosenberg 《Blood coagulation & fibrinolysis》2006,17(6):485-488
To determine whether polymorphisms of platelet surface glycoprotein associated with arterial thrombosis are risk factors for branch retinal vein occlusion. A case-control study in which 69 patients with branch retinal vein occlusion and 147 controls who attended the eye clinic for nonvascular complications participated. DNA was extracted from whole blood and analyzed for genotyping of platelet glycoprotein polymorphisms by polymerase chain reactions and specific restricted enzymes. No relationship was found between the four platelet glycoprotein polymorphisms i.e. GPIa C807T, VNTR and Kozak of glycoprotein Ibalpha, the HPA-1 of glycoprotein IIIa and the occurrence of branch retinal vein occlusion. The HPA-2 polymorphism was found in 18 out 60 (30%) patients with branch retinal vein occlusion in comparison with 27 out 142 (19%) of controls, with an estimated odds ratio of 1.8 (95% confidence interval, 0.91-3.65). The four platelet glycoprotein polymorphisms are not risk factors for branch retinal vein occlusion and therefore it seems unnecessary to screen those patients for it. A larger study is required, however, to determine whether HPA-2 is a novel risk factor for branch retinal vein occlusion. 相似文献
4.
Regulation of erythropoietin production 总被引:6,自引:0,他引:6
5.
6.
7.
8.
Leonidas JC; Berdon WE; Valderrama E; Neveling U; Schuval S; Weiss SJ; Hilfer C; Godine L 《Radiology》1996,198(2):377
9.
10.
JC Sitek† M Loeb‡ JR Ronnevig¶ 《Journal of the European Academy of Dermatology and Venereology》2007,21(7):891-896
BACKGROUND: Since 1997, a number of trials have shown promising results in treating generalized vitiligo with narrowband ultraviolet B (UVB) both in adults and children. However, there is little knowledge concerning the duration and permanency of the treatment-induced repigmentation. OBJECTIVE: Our main objective was to perform a follow-up trial of successfully treated patients receiving narrowband UVB for generalized vitiligo. METHODS: We have investigated to what degree the treatment-induced repigmentation remains stable for up to 2 years post-treatment. We performed an initial open trial including 31 patients with generalized vitiligo. They received narrowband UVB thrice weekly for up to 12 months. Patients experiencing > 75% repigmentation were defined responders and were included in the follow-up trial. Responders were followed every 6 months for up to 2 years after cessation of treatment. We observed the pigmentation status and registered any changes indicating loss of pigmentation and relapse. RESULTS: Eleven of the 31 treated patients were included in the follow-up trial. Six patients had relapse and five patients had stable response 24 months after cessation of treatment. Four out of six relapses were within 6 months post-treatment. CONCLUSION: In our study population of 31 patients with generalized vitiligo, five patients (16%) experienced > 75% stable repigmentation 2 years after cessation of a treatment programme of up to 1 years narrowband UVB therapy. 相似文献